1. Introduction {#sec1}
===============

Since H9N2 subtype avian influenza virus (AIV) was first isolated in Guangdong province of China in 1994, this subtype influenza virus has quickly spread to other areas of China and become prevalent in poultry \[[@B1]--[@B3]\]. H9N2 AIV infections in chicken flocks have led to massive economic losses due to egg production decline or high mortality related with coinfection with other pathogens \[[@B4]--[@B6]\].

Although there is no evidence for human-to-human transmission of H9N2 AIV, several human infections with H9N2 AIV have been reported \[[@B7]--[@B11]\]. It is noteworthy that the number of humans infected by H9N2 AIV in serological surveillance, especially poultry workers, was much higher than that of the confirmed cases \[[@B12], [@B13]\]. H9N2 AIV is able to reassort with other subtypes of influenza virus, including H6N1, H6N2, H5N1, and H7N9. The increased risk of animal-to-human spread with avian viruses that have the H9N2 internal genes has posed a greater pandemic threat \[[@B14]--[@B16]\].

Since the late 1990s, vaccination has been carried out in China to prevent and control H9N2 AIV infection in chicken flocks. Commercial vaccines did not provide complete protection for the endemic H9N2 AIVs in China. Up to the present time, H9N2 virus has regularly been found in vaccinated chickens in Shandong of China \[[@B1], [@B17], [@B18]\]. Therefore, this study was designed to perform a comprehensive phylogenetic analysis of H9N2 AIVs from chickens in Shandong of China to provide an important guidance for the effective control of H9N2 AIV infection.

2. Materials and Methods {#sec2}
========================

2.1. Viruses {#sec2.1}
------------

A total of 35 HA gene sequences of H9N2 AIVs isolated from chickens in Shandong of China between 1998 and 2013 were obtained from the National Center for Biotechnology Information (NCBI) Influenza Viruses Resource (<http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html>) ([Table 1](#tab1){ref-type="table"}).

2.2. Phylogenetic Analysis {#sec2.2}
--------------------------

Multiple sequence alignment was conducted using ClustalW \[[@B19]\]. The phylogenetic tree was constructed using the neighbor-joining method with 1000 bootstrap replicates using MEGA 5.05 \[[@B20]\].

2.3. Antigenic Analysis {#sec2.3}
-----------------------

Antigenic analysis of H9N2 AIV was conducted using hemagglutination inhibition (HI) to assess antigenic relationship between the emerging H9N2 AIVs and the vaccine strain SS/94 \[[@B21]\]. According to the previously published work \[[@B22]\], 6-week-old specific pathogen-free (SPF) chickens were used to produce polyclonal antibodies against 7 H9N2 AIVs, including 6 isolates between 2012 and 2013, and the vaccine strain SS/94.

3. Results {#sec3}
==========

3.1. Homology Analysis {#sec3.1}
----------------------

The coding sequences of HA gene of 35 H9N2 AIVs in this study contained 1,683 nucleotides. HA gene nucleotide sequences and deduced amino acid (AA) sequence identities among the 35 tested strains ranged from 84.0 to 100.0% and 89.1 to 100.0%, respectively. Compared with three vaccine strains, the homologies of HA nucleotide sequences and AA sequence entities of the 35 H9N2 AIVs were 84.0--93.0% and 83.6--92.2%, respectively ([Table 2](#tab2){ref-type="table"}).

3.2. Phylogenetic Analysis {#sec3.2}
--------------------------

All of 35 H9N2 AIVs belonged to the lineage h9.4.2 represented by Y280 or BJ194. The lineage h9.4.2 is divided into 6 tertiary levels: h9.4.2.1, h9.4.2.2, h9.4.2.3, h9.4.2.4, h9.4.2.5, and h9.4.2.6 \[[@B23]\]. The majority of H9N2 AIVs (21 out of 35) belonged to the lineage h9.4.2.5 represented by strains Ck/ZJ/HE6/09 and Ck/GX/55/05 \[[@B24]\]. All of 12 H9N2 AIVs isolated between 2010 and 2013 belonged to the lineage h9.4.2.5. Vaccine strains SS/94 and 6/96 belonged to the linage h9.4.2.3, and vaccine strain F/98 was clustered in the lineage h9.4.2.1 ([Figure 1](#fig1){ref-type="fig"}).

3.3. Important Site Analysis of Deduced AA Sequences {#sec3.3}
----------------------------------------------------

The cleavage sites of precursor HA protein of H9N2 AIVs showed two different motifs in this study. 33 H9N2 AIVs isolated between 1999 and 2013 had a PSRSSR↓GLF motif, which can meet the characteristic of low-pathogenic avian influenza virus ([Table 3](#tab3){ref-type="table"}).

AA residues at receptor-binding site of HA protein were conserved among the 35 H9N2 AIVs. Only one substitution was found in the position A190V(T) (H3 numbering is used throughout the paper) ([Table 3](#tab3){ref-type="table"}). On the right edge of receptor-binding pocket, AA sequences were conserved and no substitution was found in this study. AA residues on the left edge of receptor-binding pocket had a substitution Q227L (M), and most isolates (4 out of 6) between 2012 and 2013 had M at position 227. 29 out of 35 H9N2 AIVs had leucine (L) at position 226, including all of the isolates between 2005 and 2013 ([Table 3](#tab3){ref-type="table"}).

3.4. Antigenic Analysis {#sec3.4}
-----------------------

HI test was used to evaluate protection efficacy of commercial vaccine strain SS/94 widely used in Shandong against 6 H9N2 AIVs isolated in Shandong between 2012 and 2013. The results showed that antisera against 6 H9N2 AIVs (Ck/SD/YS/12, Ck/SD/WF4/12, Ck/SD/P6/12, Ck/SD/HK1/13, Ck/SD/LC1/13, and Ck/SD/LC2/13) reacted well with the emerging H9N2 AIVs (HI titer ≥ 1280), but none of antisera against the emerging H9N2 AIVs reacted well with the vaccine strain SS/94 (HI titer ≤ 320) ([Table 4](#tab4){ref-type="table"}).

4. Discussion {#sec4}
=============

Vaccination is an effective way to prevent and control the spread of H9N2 AIVs, but the current vaccine used in Shandong is still prepared from the isolates in the early 1990s, and their protective efficacy has been decreasing \[[@B3], [@B18]\]. HI test in this study showed that commercial vaccine strain SS/94 has not provided robust protection against the emerging H9N2 AIVs isolated in Shandong, China.

Previous investigation about phylogenetic analysis of HA genes of H9N2 AIVs isolated in China between 2008 and 2011 demonstrated that the lineage h9.4.2.5, as an emerging lineage, has become one of the dominant clades \[[@B22], [@B25]\]. Similarly, our findings showed that the lineage h9.4.2.5 was predominant between 2009 and 2013 in Shandong. The vaccine strain SS/94 belonged to the distinct lineage h9.4.2.3. Antigenic analysis also showed that the emerging viruses between 2012 and 2013 were antigenically different from the vaccine strain SS/94. Given the above results, it is of utmost importance to select novel candidate vaccine strains to combat the emerging H9N2 AIVs in Shandong of China.

On the left edge of receptor-binding pocket, most isolates (4 out of 6) between 2012 and 2013 had methionine (M) at position 227. But the vaccine strain SS/94 had glutamine (Q) at the same position. 33 H9N2 AIVs isolated between 1999 and 2013 had a PSRSSR↓GLF motif in HA cleavage site; the vaccine strain SS/94 had a PAGSSR↓GLF motif. Additionally, 29 out of 35 H9N2 AIVs had leucine (L) at position 226, including all of the isolates between 2005 and 2013. The substitution indicated that the emerging H9N2 AIVs can preferentially bind to NeuAca2,6-Gal linkage and may have higher virulence \[[@B3], [@B26]\].

Our findings revealed that the currently prevalent H9N2 AIVs in Shandong belonged to the lineage h9.4.2.5 which are different from the vaccine strain SS/94 clade h9.4.2.3. Furthermore, 82.9% (29/35) of H9N2 AIVs contained L at position 226, indicating that these AIVs could cross species barrier to infect humans.

5. Conclusion {#sec5}
=============

Taken together, genetic disparity between the emerging H9N2 AIVs and the current vaccine isolates should be taken into consideration when a control policy is established. In addition, the long-term surveillance of H9N2 AIVs is of significance to combat the possible H9N2 AIV outbreaks in chicken flocks.
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###### 

HA genes of 35 H9N2 AIVs isolated from Shandong of China from 1998 to 2013.

  Strains                                Abbreviation      Date of isolation   GenBank accession number
  -------------------------------------- ----------------- ------------------- --------------------------
  A/chicken/Shandong/WF/1998(H9N2)       Ck/SD/WF/98       1998                JF795136
  A/chicken/Shandong/B1/1998(H9N2)       Ck/SD/B1/98       1998                EU573939
  A/chicken/Shandong/JN/1999(H9N2)       Ck/SD/JN/99       1999                HM773437
  A/chicken/Shandong/LW/1999(H9N2)       Ck/SD/LW/99       1999                HM773438
  A/chicken/Shandong/241/2001(H9N2)      Ck/SD/241/01      2001                KF746827
  A/chicken/Shandong/3/2001(H9N2)        Ck/SD/3/01        2001                KF313566
  A/chicken/Shandong/244/2002(H9N2)      Ck/SD/244/02      2002                KF746810
  A/chicken/Shandong/BZ02/2002(H9N2)     Ck/SD/BZ02/02     2002                JQ710462
  A/chicken/Shandong/2/2003(H9N2)        Ck/SD/2/03        2003                FJ190117
  A/chicken/Shandong/S2/2005(H9N2)       Ck/SD/S2/05       2005                HM773440
  A/chicken/Shandong/JN5/2005(H9N2)      Ck/SD/JN5/05      2005                HM773436
  A/chicken/Shandong/JN4/2005(H9N2)      Ck/SD/JN4/05      2005                HM773435
  A/chicken/Shandong/ZC820/2006(H9N2)    Ck/SD/ZC820/06    2006                FJ190135
  A/chicken/Shandong/YB06/2006(H9N2)     Ck/SD/YB06/06     2006                JQ710463
  A/chicken/Shandong/LX414/2007(H9N2)    Ck/SD/LX414/07    2007                FJ190141
  A/chicken/Shandong/LX331/2007(H9N2)    Ck/SD/LX331/07    2007                FJ190140
  A/chicken/Shandong/LX327/2007(H9N2)    Ck/SD/LX327/07    2007                FJ190139
  A/chicken/Shandong/SD0014/2008(H9N2)   Ck/SD/SD0014/08   2008                HQ398361
  A/chicken/Shandong/1/2008(H9N2)        Ck/SD/1/08        2008                HQ326722
  A/chicken/Shandong/LX316/2008(H9N2)    Ck/SD/LX316/08    2008                FJ190138
  A/chicken/Shandong/BD/2009(H9N2)       Ck/SD/BD/09       2009                HM773434
  A/chicken/Shandong/SG2/2009(H9N2)      Ck/SD/SG2/09      2009                HM751194
  A/chicken/Shandong/SG1/2009(H9N2)      Ck/SD/SG1/09      2009                HM751186
  A/chicken/Shandong/YT1/2010(H9N2)      Ck/SD/YT1/10      2010                KJ419948
  A/chicken/Shandong/YT2/2010(H9N2)      Ck/SD/YT2/10      2010                KJ419946
  A/chicken/Shandong/YT4/2010(H9N2)      Ck/SD/YT4/10      2010                KJ419943
  A/chicken/Shandong/BD1/2011(H9N2)      Ck/SD/BD1/11      2011                KJ419954
  A/chicken/Shandong/YT15/2011(H9N2)     Ck/SD/YT15/11     2011                KJ419953
  A/chicken/Shandong/YT1/2011(H9N2)      Ck/SD/YT1/11      2011                KJ419947
  A/chicken/Shandong/YS/2012(H9N2)       Ck/SD/YS/12       2012                KC879302
  A/chicken/Shandong/WF4/2012(H9N2)      Ck/SD/WF4/12      2012                JX448768
  A/chicken/Shandong/P6/2012(H9N2)       Ck/SD/P6/12       2012                JX448767
  A/chicken/Shandong/HK1/2013(H9N2)      Ck/SD/HK1/13      2013                KJ419952
  A/chicken/Shandong/LC1/2013(H9N2)      Ck/SD/LC1/13      2013                KJ419951
  A/chicken/Shandong/LC2/2013(H9N2)      Ck/SD/LC2/13      2013                KJ419950

###### 

Similarity analysis of HA nucleotide sequence and deduced amino acid sequence of H9N2 AIVs and vaccine strains.

                                Virus                        Nucleotide sequence   Amino acid sequence
  ----------------------------- ---------------------------- --------------------- ---------------------
  Vaccine strains               35 H9N2 AIVs in this study   84.0--100.0%          89.1--100.0%
  A/chicken/Guangdong/SS/1994   86.2--92.1%                  83.6--87.5%           
  A/chicken/Shandong/6/1996     84.5--91.4%                  86.7--89.2%           
  A/chicken/Shanghai/F/1998     84.0--93.0%                  87.7--92.2%           

###### 

Amino acid sequence at the cleavage site and receptor-binding site of HA.

  Strain abbreviation   Left edge   Receptor-binding sites (RBS)   Right edge   Cleavage site                            
  --------------------- ----------- ------------------------------ ------------ --------------- ---- ---- ---- ---- ---- ------------
  SD/WF/98              \+          \+                             \+           \+              \+   T    \+   \+   \+   \+
  SD/B1/98              \+          \+                             \+           \+              \+   T    \+   \+   \+   \+
  SD/JN/99              NGLQGR      \+                             \+           \+              \+   \+   \+   \+   \+   PSRSSR↓GLF
  SD/LW/99              \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/241/01             \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/3/01               NGMQGR      \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/244/02             \+          \+                             \+           \+              \+   \+   \+   \+   \+   \+
  SD/BZ02/02            \+          \+                             \+           \+              \+   T    \+   \+   \+   \+
  SD/2/03               \+          \+                             \+           \+              \+   \+   \+   \+   \+   \+
  SD/S2/05              NGLQGR      \+                             \+           \+              \+   \+   \+   \+   \+   \+
  SD/JN5/05             \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/JN4/05             \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/ZC820/06           \+          \+                             \+           \+              \+   \+   \+   \+   \+   \+
  SD/YB06/06            \+          \+                             \+           \+              \+   T    \+   \+   \+   \+
  SD/LX414/07           \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/LX331/07           \+          \+                             \+           \+              \+   \+   \+   \+   \+   \+
  SD/LX327/07           \+          \+                             \+           \+              \+   T    \+   \+   \+   \+
  SD/SD0014/08          \+          \+                             \+           \+              \+   T    \+   \+   \+   \+
  SD/1/08               \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/LX316/08           \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/BD/09              \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/SG2/09             \+          \+                             \+           \+              \+   T    \+   \+   \+   \+
  SD/SG1/09             \+          \+                             \+           \+              \+   T    \+   \+   \+   \+
  SD/YT1/10             \+          \+                             \+           \+              \+   \+   \+   \+   \+   \+
  SD/YT2/10             \+          \+                             \+           \+              \+   \+   \+   \+   \+   \+
  SD/YT4/10             \+          \+                             \+           \+              \+   \+   \+   \+   \+   \+
  SD/BD1/11             \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/YT15/11            \+          \+                             \+           \+              \+   \+   \+   \+   \+   \+
  SD/YT1/11             NGLMGR      \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/YS/12              NGLQGR      \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/WF4/12             NGLMGR      \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/P6/12              \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/HK1/13             \+          \+                             \+           \+              \+   V    \+   \+   \+   \+
  SD/LC1/13             \+          \+                             \+           \+              \+   \+   \+   \+   \+   \+
  SD/LC2/13             \+          \+                             \+           \+              \+   T    \+   \+   \+   \+

*Note*. Plus signs (+) indicate identical site.

###### 

HI titers of the emerging H9N2 AIVs isolated in 2012 and 2013.

  Antigen     Antisera^A^                                                             
  ----------- ------------- ----------- ---------- ----------- ---------- ----------- ----------
  SD/YS/12    10240^B^      2560        1280       1280        1280       1280        320
  SD/WF4/12   2560          **10240**   1280       2560        1280       2560        160
  SD/P6/12    2560          5120        **2560**   1280        5120       2560        320
  SD/HK1/13   5120          10240       1280       **10240**   1280       2560        320
  SD/LC1/13   2560          5120        5120       1280        **5120**   2560        160
  SD/LC2/13   1280          2560        1280       2560        1280       **10240**   160
  SS/94       320           320         40         160         320        40          **1280**

*Notes*. ^A^Antisera were tenfold diluted; ^B^homologous tiers were marked in bold.
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